Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysisJacopo Mariotti, Stéfania Bramanti, Cristina Astrid Tentori et al.|British Journal of Haematology|2025Cited by 1